GPR37L1 Gene

GPR37L1 Gene

Introduction

Gpr37L1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@chen2012]
<div class="infobox-header">GPR37L1</div> [@dutta2014]
<div class="infobox-content"> [@im2006]
<table> [@bandopadhyay2012]
<tr><th>Full Name</th><td>GPR37L1 (Parkerin, Endothelin Receptor-Like 1)</td></tr> [@zhang2018]
<tr><th>Chromosome</th><td>chr4</td></tr> [@zhang2019]
<tr><th>Location</th><td>4q21.3</td></tr> [@soto2020]
<tr><th>NCBI Gene ID</th><td>[2842](https://www.ncbi.nlm.nih.gov/gene/2842)</td></tr>
<tr><th>OMIM</th><td>[605417](https://www.omim.org/entry/605417)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000107537](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107537)</td></tr>
<tr><th>UniProt</th><td>[O14924](https://www.uniprot.org/uniprotkb/O14924/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Multiple System Atrophy, Spastic Paraplegia, Leukodystrophy</td></tr>
<tr><th>Protein Class</th><td>Orphan GPCR, Class A Rhodopsin Family</td></tr>
<tr><th>Expression</th><td>Oligodendrocytes, Astrocytes, White Matter</td></tr>
</table>
</div>
</div>

Overview

GPR37L1 Gene

Introduction

Gpr37L1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@chen2012]
<div class="infobox-header">GPR37L1</div> [@dutta2014]
<div class="infobox-content"> [@im2006]
<table> [@bandopadhyay2012]
<tr><th>Full Name</th><td>GPR37L1 (Parkerin, Endothelin Receptor-Like 1)</td></tr> [@zhang2018]
<tr><th>Chromosome</th><td>chr4</td></tr> [@zhang2019]
<tr><th>Location</th><td>4q21.3</td></tr> [@soto2020]
<tr><th>NCBI Gene ID</th><td>[2842](https://www.ncbi.nlm.nih.gov/gene/2842)</td></tr>
<tr><th>OMIM</th><td>[605417](https://www.omim.org/entry/605417)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000107537](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107537)</td></tr>
<tr><th>UniProt</th><td>[O14924](https://www.uniprot.org/uniprotkb/O14924/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Multiple System Atrophy, Spastic Paraplegia, Leukodystrophy</td></tr>
<tr><th>Protein Class</th><td>Orphan GPCR, Class A Rhodopsin Family</td></tr>
<tr><th>Expression</th><td>Oligodendrocytes, Astrocytes, White Matter</td></tr>
</table>
</div>
</div>

Overview

GPR37L1 (G protein-coupled receptor 37-like 1), also known as Endothelin Receptor-Like 1 (ETRL1) or Parkerin, is an orphan G-protein coupled receptor highly expressed in the brain, particularly in oligodendrocytes and [astrocytes](/entities/astrocytes). GPR37L1 plays crucial roles in protein quality control, oligodendrocyte function, and myelination. The receptor has been implicated in Parkinson's disease and multiple system atrophy through its aggregation in affected brains and interactions with the parkin E3 ubiquitin ligase. Pathogenic mutations in GPR37L1 cause hereditary spastic paraplegia, highlighting its importance in white matter integrity.

Gene Structure

The GPR37L1 gene is located on chromosome 4q21.3 and consists of 4 exons spanning approximately 6 kb. The gene encodes a 462-amino acid GPCR protein with a molecular weight of approximately 50 kDa. The gene is expressed primarily in the brain with highest levels in white matter regions. Alternative splicing produces multiple transcript variants with differential tissue distribution.

Protein Structure

GPR37L1 has the characteristic seven-transmembrane domain structure of GPCRs:

• N-terminal Extracellular Domain: Contains multiple glycosylation sites
• Transmembrane Domains: Seven α-helices (TM1-TM7) spanning the membrane
• Intracellular Loops: Contain phosphorylation sites for regulation
• C-terminal Intracellular Domain: Contains PDZ-binding motif

Normal Function

G Protein Signaling

• Activation leads to protein kinase A (PKA) activation
• Regulates cAMP-dependent transcription
• May modulate neuronal excitability
• Links to metabolic regulation

Protein Quality Control

• Substrate for the parkin E3 ligase
• Regulates ER-associated degradation (ERAD)
• May clear misfolded proteins
• Links to [autophagy](/entities/autophagy) pathways

Oligodendrocyte Function

• Regulates oligodendrocyte precursor cell (OPC) differentiation
• Essential for myelination
• Supports oligodendrocyte survival
• Maintains myelin integrity

Neuroprotection

• Prosaposin binding activates pro-survival signaling
• Protects against ER stress
• May modulate neuroinflammation

Disease Associations

Parkinson's Disease

• Aggregation: GPR37L1 protein aggregates found in Lewy bodies in PD brains
• Parkin Interaction: Substrate for parkin E3 ligase; loss of parkin function leads to accumulation
• Dopaminergic Neuron Vulnerability: Expressed in substantia nigra; dysfunction may contribute to neuron loss
• Genetic Variants: Association studies suggest links to PD risk

Multiple System Atrophy (MSA)

• GPR37L1 aggregates in oligodendrocytes in MSA brains
• Contributes to oligodendrocyte degeneration
• Part of the [α-synuclein](/proteins/alpha-synuclein) pathology
• Linked to demyelination

Hereditary Spastic Paraplegia (HSP)

• Mutations in GPR37L1 cause autosomal recessive HSP
• Presents with lower limb spasticity and weakness
• Associated with thin corpus callosum
• Variable cognitive impairment

Leukodystrophies

• GPR37L1 dysfunction linked to hypomyelinating disorders
• Impaired oligodendrocyte function
• White matter abnormalities on MRI

Other Neurodegenerative Conditions

• Alzheimer's Disease: Altered expression in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
• Amyotrophic Lateral Sclerosis: May affect oligodendrocyte support
• Huntington's Disease: Dysregulated in striatum

Expression Pattern

GPR37L1 exhibits a specific expression pattern:

• Highest Expression: White matter regions (corpus callosum, internal capsule, centrum semiovale)
• Cell Types: Oligodendrocyte precursor cells, mature oligodendrocytes, astrocytes
• Brain Regions: Cerebellum, brainstem, spinal cord
• Peripheral: Low expression in testis, kidney

Molecular Mechanisms

Parkin-Mediated Degradation

• Parkin ubiquitinates GPR37L1
• Targets for proteasomal degradation
• Loss of parkin function leads to accumulation
• Contributes to aggregate formation

Prosaposin Signaling

• Prosaposin is a neurotrophic factor
• GPR37L1 mediates prosaposin effects
• Protects against [apoptosis](/entities/apoptosis)
• Supports oligodendrocyte survival

ER Stress Response

• Monitors protein folding
• Activates [unfolded protein response](/entities/unfolded-protein-response)
• Links to ERAD pathway
• May trigger apoptosis under stress

cAMP Signaling

• Gαs-coupled signaling
• Regulates PKA activity
• Affects gene transcription
• Modulates neuronal function

Therapeutic Implications

Small Molecule Modulators

• cAMP enhancers: Increase GPR37L1 signaling
• ER stress modulators: Reduce protein aggregation
• Prosaposin analogs: Activate neuroprotective pathways

Gene Therapy Approaches

• AAV-GPR37L1 for oligodendrocyte support
• CRISPR correction of mutations
• siRNA to reduce toxic aggregates

Protein-Based Therapies

• Prosaposin administration
• Neurotrophic factor delivery
• Antibody-based approaches

Combination Strategies

• GPR37L1 modulation + α-synuclein immunotherapy
• Myelin repair + neuroprotection
• Oligodendrocyte support + anti-inflammatory

Animal Models

Knockout Mice

• GPR37L1 KO: Viable with subtle neurological deficits
• Hypomyelination in white matter
• Altered oligodendrocyte numbers
• Motor coordination deficits

Transgenic Models

• Overexpression: Aggregation and pathology
• PD models: α-synuclein + GPR37L1
• Reporter lines: GFP-GPR37L1

Zebrafish Models

• Morpholino knockdown: Developmental defects
• Myelin abnormalities

Research Directions

• Developing GPR37L1-targeted drugs
• Understanding aggregation mechanisms
• Biomarker development for white matter disorders
• Clinical translation

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [G Protein](/proteins/gpr37l1-protein)
• [Myelin Pathway](/mechanisms/myelin-pathway)
• [Parkin Gene](/proteins/parkin-protein)

External Links

• [NCBI Gene: GPR37L1](https://www.ncbi.nlm.nih.gov/gene/2842)
• [UniProt: GPR37L1](https://www.uniprot.org/uniprotkb/O14924/entry)
• [Ensembl: GPR37L1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000107537)
• [OMIM: GPR37L1](https://www.omim.org/entry/605417)

Background

The study of Gpr37L1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References